Arginomycin: production, isolation, characterization and structure.
Arginomycin is a new nucleoside antibiotic produced by Streptomyces arginesis. Arginomycin, C18H28N8O5, which inhibits the growth of Gram-positive bacteria and fungi in vitro, is structurally related to blasticidin S and found to be relatively non-toxic.
D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents; D055598:Chemical Phenomena; D002621:Chemistry; D002845:Chromatography; D005658:Fungi / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D007928:Lethal Dose 50; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D051379:Mice; D009705:Nucleosides / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology; D013053:Spectrophotometry; D013302:Streptomyces / Q000378:metabolism*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D009705:Nucleosides; C053076:arginomycin